Stock listing
Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A
Selected listing: 002294 · SZSE · CNY · CN
Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A (Shenzhen:002294), Health Technology. Latest release Apr 21, 2026: Shenzhen Salubris Pharmaceuticals…
- Ticker
- Shenzhen:002294
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shenzhen
- Currency
- CNY
About Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A
The company specializes in the pharmaceutical industry, focusing on the development and production of innovative healthcare solutions. As a key player in the market, Salubris aims to enhance patient care through its diverse range of products.
Latest news from Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A
Shenzhen Salubris Pharmaceuticals : Revenue up 8.5%, net profit up 8.3%, innovative drug sales up 47% year-over-year
April 21, 2026
Shenzhen Salubris Pharmaceuticals Plans To Seek Hong Kong Listing
January 21, 2026
Shenzhen Salubris Pharmaceuticals Co: Q3 2025 saw 15.85% revenue growth and 30.19% net profit increase, led by new products
October 28, 2025
Shenzhen Salubris Pharmaceuticals Co: Net profit rose 6.10% on 4.32% revenue growth, led by new drugs and medical device expansion
August 20, 2025
Shenzhen Salubris Pharmaceuticals Co: Patented and new product growth offset generic drug declines, keeping Q1 profit stable
April 22, 2025
All Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A news →
Research Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A
Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A company profile
View the public company page for Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A on 6ix.
Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A news
Read company news and market updates connected to Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A.
Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A.